The best indicator for F5, Inc. (FFIV)
We backtested 366 indicators across daily, weekly and hourly charts on real F5, Inc. (FFIV) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
RSI Trend (>50)
On the daily chart, this is the strongest risk-adjusted edge we found for F5, Inc. (FFIV) over ~27.0 years — beating buy-and-hold by 3.6% CAGR.
Best multi-indicator combo
Going long only when all 3 agree was the strongest confluence setup we found for F5, Inc. (FFIV) — trailing buy-and-hold by 4.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | RSI Trend (>50) ✓ | Daily | 19.4% | 0.64 | -66.8% | 41.5% | 323 | 3.6% |
| 2 | Price Volume Trend ✓ | Daily | 20.1% | 0.64 | -86.9% | 41.3% | 252 | 4.2% |
| 3 | Ehlers Decycler ✓ | Daily | 19.4% | 0.63 | -55.7% | 42.8% | 416 | 3.6% |
| 4 | PMax ✓ | Daily | 18.9% | 0.62 | -64.6% | 42.9% | 42 | 3.0% |
| 5 | KAMA 100 Trend ✓ | Daily | 18.2% | 0.61 | -70.0% | 41.1% | 151 | 2.3% |
| 6 | Volume Zone Oscillator ✓ | Daily | 17.4% | 0.6 | -68.4% | 43.0% | 639 | 1.5% |
| 7 | Cutler's RSI ✓ | Daily | 17.1% | 0.59 | -62.9% | 42.4% | 377 | 1.2% |
| 8 | ROC (14) ✓ | Daily | 17.1% | 0.59 | -62.9% | 42.4% | 377 | 1.2% |
| 9 | CMO (14) ✓ | Daily | 17.1% | 0.59 | -62.9% | 42.4% | 377 | 1.2% |
| 10 | DeMarker (14) ✓ | Daily | 17.1% | 0.59 | -60.4% | 44.6% | 323 | 1.3% |
| 11 | HalfTrend ✓ | Weekly | 18.6% | 0.59 | -83.8% | 41.9% | 31 | 2.8% |
| 12 | McGinley Dynamic ✓ | Daily | 18.3% | 0.58 | -85.3% | 38.5% | 288 | 2.4% |
| 13 | Williams Fractals ✓ | Daily | 16.7% | 0.58 | -79.9% | 47.7% | 151 | 0.8% |
| 14 | Supertrend (14,4) ✓ | Daily | 16.6% | 0.58 | -75.5% | 49.2% | 59 | 0.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For F5, Inc. (FFIV), RSI Trend (>50) on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.